RA Capital Management »

Spyglass Pharma shares owned by RA Capital Management

Quarter-by-quarter ownership of Spyglass Pharma shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Spyglass Pharma

Tip: Access up to 7 years of quarterly data

All positions including Spyglass Pharma held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spyglass Pharma by RA Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $208M 8.0M 25.91

More positions owned by RA Capital Management

Ascendis Pharma A/s - Sponsored Adr (ASND)
Vaxcyte Common Stock (PCVX)
Rhythm Pharmaceuticals Common Stock (RYTM)
Tyra Biosciences Common Stock (TYRA)
Sionna Therapeutics Common Stock (SION)
Edgewise Therapeutics Common Stock (EWTX)
Newamsterdam Pharma Co Nv Common Stock (NAMS)
Nuvalent Inc-a Common Stock (NUVL)
Dianthus Therapeutics Common Stock (DNTH)
Mineralys Therapeutics Common Stock (MLYS)
Spyglass Pharma Common Stock
Wave Life Sciences Common Stock (WVE)
Septerna Common Stock (SEPN)
Disc Medicine Common Stock (IRON)
Janux Therapeutics Common Stock (JANX)

View all positions for RA Capital Management

Top funds holding Spyglass Pharma

RA Capital Management
NEA Management Company
Sands Capital Ventures
Samsara BioCapital
Vestal Point Capital
Deerfield Management Company
Millennium Management
Vanguard Capital Management
First Light Asset Management
Franklin Resources
Standard Life Aberdeen
BlackRock
Geode Capital Management
Monashee Investment Management
Vanguard Fiduciary Trust

View all funds holding Spyglass Pharma